Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Low levels of tenuazonic acid can severely damage vital organs.

Some blood pressure medications are linked to a higher risk of skin cancer.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

The hydrogel helps heal diabetic wounds by reducing infection and inflammation.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.